13 February 2012 - Life sciences company SeraCare Life Sciences Inc (NASDAQ:SRLS) reported on Friday its net income of USD1.0m (USD0.05 per share on a basic and diluted basis) for its 2012 fiscal first quarter ended 31 December 2011.

This reflects a drop when compared with net income of USD1.6m (USD0.08 per share on a basic and diluted basis) for the same quarter in fiscal 2011.

Revenue of USD11.4m was generated for the quarter ended 31 December 2011, up 9% when compared with revenues of USD10.5m for the quarter ended 31 December 2010.

Non-GAAP net income of USD1.4m (USD0.07 per share) was reported for the fiscal 2012 first quarter, a growth when compared to non-GAAP net income of USD0.7m (USD0.04 per share) for the fiscal 2011 first quarter.